Title |
Blocking of Striated Muscle Degeneration by Serotonin in C. elegans
|
---|---|
Published in |
Journal of Muscle Research and Cell Motility, June 2006
|
DOI | 10.1007/s10974-006-9070-9 |
Pubmed ID | |
Authors |
Maité Carre-Pierrat, Marie-Christine Mariol, Lucie Chambonnier, Aurélie Laugraud, Fabienne Heskia, Jean Giacomotto, Laurent Ségalat |
Abstract |
Prevention of muscle fiber degeneration is a key issue in the treatment of muscular dystrophies such as Duchenne Muscular Dystrophy (DMD). It is widely postulated that existing pharmaceutical compounds might potentially be beneficial to DMD patients, but tools to identify them are lacking. Here, by using a Caenorhabditis elegans model of dystrophin-dependent muscular dystrophy, we show that the neurohormone serotonin and some of its agonists are potent suppressors of muscle degeneration. Inhibitors of serotonin reuptake transporters, which prolong the action of endogenous serotonin, have a similar effect. Moreover, reduction of serotonin levels leads to degeneration of non-dystrophic muscles. Our results demonstrate that serotonin is critical to C. elegans striated muscles. These findings reveal a new function of serotonin in striated muscles. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Unknown | 33 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 26% |
Student > Ph. D. Student | 6 | 18% |
Student > Master | 6 | 18% |
Other | 2 | 6% |
Student > Bachelor | 2 | 6% |
Other | 4 | 12% |
Unknown | 5 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 13 | 38% |
Biochemistry, Genetics and Molecular Biology | 6 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
Engineering | 2 | 6% |
Environmental Science | 1 | 3% |
Other | 4 | 12% |
Unknown | 6 | 18% |